Back Stocks profile

Stock analysis tool for investors

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE:524715

₹1559.25 -18.70 (-1.19%) 1D

Pharmaceuticals & Biotechnology

Open an Account with Bigul in 5 minutes

Performance

Today’s low

1548.00

Today’s High

1581.90

52W low

922.40

52W High

1587.80

Open Price

1580.00

Prev. Close

1577.9500

Volume

4211656.00

Value

6567024618.00

Fundamentals

Market Cap Cr

374116.30

Price to Earnings

42.00

Price to Book Value

6.30

Dividend Yield

0.80

PE to Growth

0.40

Op Revenue TTM Cr

47444.62

Net Profit TTM Cr

8906.27

Cash From Operating Activity Cr

4959.33

Return on Equity %

15.13

EMA & SMA

Bullish Moving Averages

14

Bearish Moving Averages

2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

01 Mar, 2024

73.7

Week

71.6

Month

65.3

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

1563.07

PIVOT

First Resistance

1578.08

Second Resistance

1596.92

Third Resistance

1611.93

First Support

1544.23

Second Support

1529.22

Third Support

1510.38

Relative Strength Index

67.82

Money Flow Index

51.06

MACD

48.28

MACD Signal

52.1

Average True Range

29.27

Average Directional Index

62.36

Rate of Change (21)

10.75

Rate of Change (125)

40.27

Commodity Channel Index

81.2

Williams %R

-34.4

BETA

1 Month

-0.09

3 Month

0.18

1 Year

0.15

3 Year

0.05

PRICE CHANGE ANALYSIS

-0.13%

1 Week

Low

High

1548.05

1587.8

10.75%

1 Month

Low

High

1405.15

1587.8

26.64%

3 Months

Low

High

1208.55

1587.8

40.6%

6 Months

Low

High

1068.35

1587.8

62.54%

1 Year

Low

High

922.45

1587.8

Bigul
01 Mar 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation regarding issuance of Letter of confirmation in lieu of duplicate share certificate.
28 Feb 2024

Sun Pharma's Dilip Shanghvi Aims To Raise R&D Spend To $1 Billion NDTV Profit Exclusive

Dilip Shanghvi aspires to increase Sun Pharma's research and development spend to a billion dollars in the next three to five years.
Bigul
20 Feb 2024

Sun Pharma to acquire 16.33 per cent in Surgimatix Inc, for $ 3.05 million

The Illinois-headquartered company is engaged in developing a proprietary soft tissue fixation device for laparoscopic hernia repair and other minimally invasive surgeries
Bigul
20 Feb 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Acquisition

This is to inform that the Company (together with its subsidiaries) has entered into an agreement with Surgimatix Inc. pursuant to which the company has agreed to acquire 16.33% shares of Surgimatix Inc.
Bigul
12 Feb 2024

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regulatory Order

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Regulatory Order
See all News

FAQs

The latest market price of Sun Pharmaceutical Industries Ltd. on NSE was Rs. 1559.25 as of today.

The opening share price of Sun Pharmaceutical Industries Ltd. was Rs. 1580.00 as of today.

The 52-week high share price of Sun Pharmaceutical Industries Ltd. was Rs. 1587.80.

The 52 week low share price of Sun Pharmaceutical Industries Ltd. was Rs. 922.40.

Sun Pharmaceutical Industries Ltd. has a market cap of Rs. 374116.30 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Sun Pharmaceutical Industries Ltd. is 0.40. Please refer to the Fundamentals section for further details.

The operating revenue for Sun Pharmaceutical Industries Ltd. in the last FY was Rs.  47444.62 crore. Please refer to the Financials section for further details.

The Net Profit for Sun Pharmaceutical Industries Ltd. in the last FY was Rs. 8906.27 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Sun Pharmaceutical Industries Ltd. was on 2024-02-09 for Rs. 8.5 per share. According to today’s share price, the dividend yield of Sun Pharmaceutical Industries Ltd. stands at 0.80. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Sun Pharmaceutical Industries Ltd. was as of 2013-07-29. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Sun Pharmaceutical Industries Ltd. was as of 2003-01-13. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Sun Pharmaceutical Industries Ltd..